每月彙整：八月 2021

北大教授突然傳來 : 證明聖經預言真實可信! 繼續閱讀 →

《@老謝看世界 》2021.08.28 習近平「共同富裕」令下 中概股一夕回到解放前？ 陳松興、乾隆來 繼續閱讀 →

Delays can feel agonizing, but God has a bird’s-eye view and His timing is perfect. In this practical message, Dr. Stanley talks about six things you need in order to receive God’s best in every situation. 繼續閱讀 →

聖經鳥瞰5 出埃及記 一幅完整救贖的圖畫(王生台弟兄) 繼續閱讀 →

數字台灣HD370台灣數位轉型的機會與挑戰 謝金河 許毓仁 余宛如 繼續閱讀 →

《@老謝看世界 》2021.08.21 PC狂賣到頂？宏碁「虎虎生風」高毛利衝高 陳俊聖 繼續閱讀 →

Judgment—it’s a heavy word that inspires anxiety, dread, and possibly despair. But for the believer, it doesn’t have to be that way. In this message, Dr. Stanley explains that judgment for Christians isn’t something we have to be afraid of. Yes, we will be held accountable for our lives, but God’s desire is to reward His children, not punish them. Learn how to live in such a way that one day you’ll hear the words, “Well done, my good and faithful servant.” 繼續閱讀 →

聖經鳥瞰4B 亞伯拉罕的神，以撒的神，雅各的神 (王生台弟兄) 繼續閱讀 →

聯生藥 (United BioPharma；UBP) 今日宣布，台灣衛生福利部食品藥物管理署(TFDA)與中國國家藥品監督管理局(NMPA)皆已分別核准UB-421之一項概念性 (Proof Of Concept) 二期床試驗IND (臨床試驗編號 A232和 A230)。該臨床試驗目的在於評估穩定接受抗逆轉錄病毒療法 (Antiretroviral Therapy；ART)且病毒被抑制的愛滋病患者中，使用 UB-421(一種抗 CD4 單株抗體) 單藥療法 (monotherapy) 或與西達本胺(Chidamide，一種潛伏病毒逆轉劑；latency reversal agent；LRA) 倂用在 HIV-1 功能性治癒(functional cure)中的應用。 繼續閱讀 →

Taipei, Taiwan –Aug. 17, 2021 –United BioPharma (UBP) announced today that two separated Investigational New Drug (IND) approvals have been granted by Taiwan FDA (UBP protocol No. A232) and by China National Medical Products Administration (NMPA; protocol No. A230) for two phase 2 proof-of-concept (POC) trials with UB-421 (an anti-CD4 monoclonal antibody) monotherapy alone or in combination with chidamide, a latency reversal agent (LRA), among virally suppressed patients under stable treatment with antiretroviral therapy (ART) to evaluate the application in HIV-1 functional cure. The objective is to examine the reduction of HIV reservoirs and dynamics of related biomarkers that may shed lights into the mechanism of “shock-and-kill” to achieve the HIV functional cure. The two POC studies with slightly different designs will be conducted in Kaohsiung Veteran General Hospital, Taiwan (A232 trial) and Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangdong China (A230 trial), respectively. 繼續閱讀 →

數字台灣HD369 避開陷阱，小心地雷股！ 謝金河 葉銀華 陳春山 繼續閱讀 →